2019

Doege D, Thong M, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V.
The role of psychosocial resources for long-term breast, colorectal, and prostate cancer survivors: prevalence and associations with health-related quality of life.
Support Care Cancer 2019;27(1):275-286.

2018

Adam S, Feller A, Rohrmann S, Arndt V.
Health-related quality of life among long-term (>/=5 years) prostate cancer survivors by primary intervention: a systematic review.
Health Qual Life Outcomes 2018;16(1):22.

Arndt V, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Pritzkuleit R, Waldeyer-Sauerland M,  Waldmann A, Zeissig SR, Doege D, Thong MSY, Brenner H.
Return to work after cancer. A multi-regional population-based study from Germany.
Acta Oncologica (in press)

Eyl RE, Koch-Gallenkamp L, Jansen L, Walter V, Carr P, Hoffmeister M, Chang-Claude J, Brenner H, Arndt V.
Potential determinants of physical inactivity among long-term colorectal cancer survivors.
J Cancer Surviv 2018;12(5):679-690.

Eyl RE, Xie K, Koch-Gallenkamp L, Brenner H, Arndt V.
Quality of life and physical activity in long-term (>/=5 years post-diagnosis) colorectal cancer survivors - systematic review.
Health Qual Life Outcomes 2018;16(1):112.

Thong MSY, Mols F, Doege D, van de Poll-Franse L, Arndt V.
Population-based cancer survivorship research: Experiences from Germany and the Netherlands.
Journal of Cancer Policy 2018.

Thong MSY, Wolschon E-M, Koch-Gallenkamp L, Waldmann A, Waldeyer-Sauerland M, Pritzkuleit R, Bertram H, Kajüter H, Eberle A, Holleczek B, Zeissig SR, Brenner H, Arndt V. “Still a Cancer Patient”—Associations of Cancer Identity With Patient-Reported Outcomes and Health Care Use Among Cancer Survivors.
JNCI Cancer Spectrum 2018;2(2).

Thong MSY, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V.
Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls -- A population-based study.
Acta Oncologica (in press)

2017

Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Schmid-Hopfner S, Waldmann A, Zeissig SR, Brenner H.
Quality of life in long-term and very long-term cancer survivors versus population controls in Germany.
Acta Oncol 2017;56(2):190-197.

Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V.
Progredienzangst ≥5 Jahre nach Krebsdiagnose.
Der Onkologe 2017;23(4):295-299.

2016

Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Hopfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V.
Fear of recurrence in long-term cancer survivors-Do cancer type, sex, time since diagnosis, and social support matter?
Health Psychol 2016;35(12):1329-1333.

 

nach oben